Jennifer Maynard
#184,842
Most Influential Person Now
Chemical Engineering researcher
Jennifer Maynard's AcademicInfluence.com Rankings
Jennifer Maynardchemistry Degrees
Chemistry
#5777
World Rank
#7005
Historical Rank
Chemical Engineering
#815
World Rank
#836
Historical Rank
Download Badge
Chemistry
Jennifer Maynard's Degrees
- PhD Chemical Engineering University of California, Berkeley
- Bachelors Chemical Engineering University of Texas at Austin
Why Is Jennifer Maynard Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jennifer Maynard is an American chemist who is the Henry Beckman Professor in Chemical Engineering at the University of Texas at Austin. Her research considers the development of therapeutic targets for infectious diseases. She was elected a Senior Member of the National Academy of Inventors in 2023.
Jennifer Maynard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes (2020) (449)
- Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes (2020) (407)
- Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity (2002) (284)
- Structural evidence for a germline-encoded T cell receptor–major histocompatibility complex interaction 'codon' (2007) (241)
- Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. (2005) (183)
- Rhizoremediation of Trichloroethylene by a Recombinant, Root-Colonizing Pseudomonas fluorescensStrain Expressing Toluene ortho-Monooxygenase Constitutively (1998) (155)
- Concentrated dispersions of equilibrium protein nanoclusters that reversibly dissociate into active monomers. (2012) (108)
- Surface plasmon resonance for high‐throughput ligand screening of membrane‐bound proteins (2009) (96)
- Nanohole-based surface plasmon resonance instruments with improved spectral resolution quantify a broad range of antibody-ligand binding kinetics. (2012) (96)
- A Novel All Helix Fold of the AP180 Amino-Terminal Domain for Phosphoinositide Binding and Clathrin Assembly in Synaptic Vesicle Endocytosis (2001) (92)
- In vivo whole animal fluorescence imaging of a microparticle-based oral vaccine containing (CuInSe(x)S(2-x))/ZnS core/shell quantum dots. (2013) (91)
- When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions (2018) (63)
- Frozen-state storage stability of a monoclonal antibody: aggregation is impacted by freezing rate and solute distribution. (2013) (61)
- Forward engineering of synthetic bio-logical and gates (2008) (61)
- Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing* (2015) (58)
- Recent Advances Incorporating Superparamagnetic Nanoparticles into Immunoassays (2018) (51)
- A cocktail of humanized anti–pertussis toxin antibodies limits disease in murine and baboon models of whooping cough (2015) (47)
- High-level bacterial secretion of single-chain αβ T-cell receptors (2005) (44)
- Crystallization chaperone strategies for membrane proteins. (2011) (41)
- Antibody engineering. (2000) (38)
- Crystal structure of the engineered neutralizing antibody M18 complexed to domain 4 of the anthrax protective antigen. (2009) (38)
- Modeling the structure of mAb 14B7 bound to the anthrax protective antigen (2007) (37)
- The Skp chaperone helps fold soluble proteins in vitro by inhibiting aggregation. (2012) (36)
- Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization (2011) (32)
- Tunable equilibrium nanocluster dispersions at high protein concentrations (2013) (30)
- Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7. (2009) (29)
- The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes (2021) (29)
- Identification of a conserved neutralizing epitope present on spike proteins from all highly pathogenic coronaviruses (2021) (28)
- Viscosity Reduction of a Concentrated Monoclonal Antibody with Arginine·HCl and Arginine·Glutamate (2016) (26)
- De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide (2017) (26)
- Back to the future: recombinant polyclonal antibody therapeutics (2013) (25)
- Progress towards recombinant anti-infective antibodies. (2009) (24)
- Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice (2018) (24)
- Engineering therapeutic antibodies to combat infectious diseases. (2018) (24)
- Charge Shielding Prevents Aggregation of Supercharged GFP Variants at High Protein Concentration. (2017) (23)
- The Bordetella Adenylate Cyclase Repeat-in-Toxin (RTX) Domain Is Immunodominant and Elicits Neutralizing Antibodies* (2014) (20)
- Bioavailability of Fullerene under Environmentally Relevant Conditions: Effects of Humic Acid and Fetal Bovine Serum on Accumulation in Lipid Bilayers and Cellular Uptake. (2016) (20)
- Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons (2020) (19)
- Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display (2019) (19)
- Expression and characterization of SARS-CoV-2 spike proteins (2021) (18)
- High-level bacterial secretion of single-chain alphabeta T-cell receptors. (2005) (17)
- Synergistic Neutralization of Pertussis Toxin by a Bispecific Antibody In Vitro and In Vivo (2016) (15)
- Conversion of scFv peptide-binding specificity for crystal chaperone development. (2011) (15)
- Microarrays in infection and immunity (2007) (14)
- A facile technology for the high-throughput sequencing of the paired VH:VL and TCRβ:TCRα repertoires (2020) (14)
- Restriction enzyme-free construction of random gene mutagenesis libraries in Escherichia coli. (2012) (14)
- The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. (2015) (14)
- Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability. (2012) (14)
- Identification of high affinity HER2 binding antibodies using CHO Fab surface display (2018) (14)
- Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin. (2017) (13)
- Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization. (2015) (12)
- SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines (2022) (11)
- Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization (2018) (10)
- Measurement of Two‐Photon Absorption of Silicon Nanocrystals in Colloidal Suspension for Bio‐Imaging Applications (2018) (10)
- Effects of protein engineering and rational mutagenesis on crystal lattice of single chain antibody fragments (2014) (9)
- Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking (2018) (9)
- In vitro scanning-saturation mutagenesis. (2002) (8)
- Increased Fab thermoresistance via VH-targeted directed evolution. (2015) (8)
- Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes (2021) (7)
- Bioproduced Proteins On Demand (Bio-POD) in hydrogels using Pichia pastoris (2021) (7)
- The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes (2022) (7)
- Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis (2016) (6)
- Inclusion of an RGD Motif Alters Invasin Integrin-Binding Affinity and Specificity. (2016) (6)
- Immunotherapeutic Approaches To Prevent Cytomegalovirus-Mediated Disease. (2014) (5)
- Characterizing the innate and adaptive responses of immunized mice to Bordetella pertussis infection using in vivo imaging and transcriptomic analysis (2019) (5)
- Addressing Future Engineering Educators Through ASEE (2000) (3)
- Erratum: The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies (The Journal of Biological Chemistry (2015) 290 (3576-3591)) (2015) (3)
- Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin (2022) (3)
- Basics of pertussis pathogenesis (2018) (3)
- Flanking Residues Are Central to DO11.10 T Cell Hybridoma Stimulation by Ovalbumin 323–339 (2012) (2)
- An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH (2022) (2)
- Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis (2022) (2)
- Elucidating the mechanism of cellular uptake of fullerene nanoparticles (2021) (1)
- Enhancing the immunotherapeutic Trastuzumab for selective activity in the low pH tumor microenvironment (2018) (1)
- Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection (2022) (1)
- Architecture and antigenicity of the nipah virus attachment glycoprotein (2022) (1)
- One step ultra-high-throughput sequencing of the paired antibody VH:VL and TCRβ:α repertoires using cell lysate resistant xenopolymerase in emulsion (2020) (1)
- Engineering Antibody-Based Therapeutics: Progress and Opportunities (2021) (1)
- Engineering Antibodies on the Surface of CHO Cells. (2020) (1)
- Crystal structure of mouse TCR 172.10 complexed with MHC class II I-Au molecule at 2.4 A (2005) (0)
- The Use of Engineered Antibody Fragments to Promote Crystallization of Membrane Proteins (2014) (0)
- Engineering T cell receptors for improved therapeutic T regulatory cell (Treg) function (2017) (0)
- Antibody engineering on the surface of CHO cells (2017) (0)
- Crystal structure of engineered anti-EE scFv antibody fragment (2014) (0)
- Novel approaches to prevent and treat pertussis (2017) (0)
- Crystal structure of anthrax-neutralizing single-chain antibody 14b7 (2009) (0)
- Crystal structure of engineered antibody fragment based on 3D5 (2011) (0)
- Engineering next generation therapeutics to combat infectious diseases (2019) (0)
- Passive Immunization with Anti-Pertussis Toxin Humanized Monoclonal Antibody Mitigates Clinical Signs of Pertussis Infection in Newborn Baboons (2017) (0)
- The Bordetella Adenylate Cyclase Toxin RTX Domain is Immunodominant and Elicits Neutralizing Antibodies (2014) (0)
- Finding murine t-cell receptor repertoire shifts due to ovalbumin challenges using high throughput sequencing (2012) (0)
- Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses (2023) (0)
- APS March Meeting 2012 (2012) (0)
- Outsmarting Pathogens with Antibody Engineering. (2023) (0)
- Engineering hyper-crystallizable single chain antibodies for crystallization scaffold (2008) (0)
- Restriction enzyme-free construction of random gene mutagenesis libraries in E. coli (2012) (0)
- Engineering antibodies for conditional activity in the solid tumor microenvironment. (2022) (0)
- Editorial overview - Biological engineering: Emerging strategies to understand & engineer the human immune system (2018) (0)
- Recombinant antibodies recognize conformation-dependent epitopes of the leucine zipper of misfolding-prone myocilin (2021) (0)
- Engineering antibody therapeutics : approaches to neutralizing bacterial toxins (2002) (0)
- De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide (2017) (0)
- The Evolution Of Engineering Incorporating Biology Into Traditional Engineering Curriculum (1999) (0)
- The SARS-CoV-2 spike protein reversibly samples an open-trimer conformation exposing novel epitopes (2022) (0)
- CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF DROSOPHILA AP180 (2001) (0)
- Next-generation antibody and TCR therapeutics for infectious disease (2017) (0)
This paper list is powered by the following services:
Other Resources About Jennifer Maynard
What Schools Are Affiliated With Jennifer Maynard?
Jennifer Maynard is affiliated with the following schools:
